COLITIS
Clinical trials for COLITIS explained in plain language.
Never miss a new study
Get alerted when new COLITIS trials appear
Sign up with your email to follow new studies for COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for immunotherapy side effects: which drug works best?
Disease control OngoingThis study compares two medications, infliximab and vedolizumab, for treating colitis (colon inflammation) caused by immune checkpoint inhibitor therapy in cancer patients. About 47 adults with genitourinary cancer, melanoma, or non-small cell lung cancer will receive one of thes…
Matched conditions: COLITIS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
Gut bacteria therapy aims to tame immunotherapy side effect
Disease control TerminatedThis study tested whether a treatment made from healthy gut bacteria (called restorative microbiota therapy) is safe and possible for people with severe colon inflammation caused by cancer immunotherapy. It was designed for patients whose colitis did not improve with steroids. Th…
Matched conditions: COLITIS
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New Light-Based scanner aims to spot inflammation without needles
Diagnosis TerminatedThis study is testing a new, non-invasive imaging device called MSOT that uses light and sound to detect inflammation in the skin or gut. It includes 100 adults with graft-versus-host disease, Crohn's disease, or colitis. The main goal is to see if the device is safe and can help…
Matched conditions: COLITIS
Phase: NA • Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated May 17, 2026 02:03 UTC
-
Texting your doctor: a new way to manage IBD?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether people with inflammatory bowel disease (IBD) have better outcomes and feel more in control of their health when they can text their medical team and regularly report symptoms via text surveys. About 900 participants will be split into two groups: one g…
Matched conditions: COLITIS
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC